2.13
price up icon8.67%   0.17
after-market Handel nachbörslich: 2.14 0.01 +0.47%
loading

Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
11.01%
0.121
0.109 0.165 0.163 0.205
Operating Expenses
2.81%
14.90
14.49 12.77 12.71 11.14
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
2.81%
14.90
14.49 12.77 12.71 11.14
Operating Income/Loss
2.75%
-14.78
-14.38 -12.60 -12.54 -10.93
Nonoperating Income/Loss
12.03%
0.834
0.948 0.746 0.767 0.922
Income/Loss From Continuing Operations Before Tax
100.90%
0.121
-13.43 0.165 -11.78 -10.01
Income/Loss From Continuing Operations After Tax
3.79%
-13.94
-13.43 -11.86 -11.78 -10.01
Net Income/Loss
3.79%
-13.94
-13.43 -11.86 -11.78 -10.01
Preferred Stock Dividends And Other Adjustments
0.006
- 0.006 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
66.53
66.52 46.87 44.83 44.68
Diluted Average Shares
0.00%
66.53
66.52 46.87 44.83 44.68
Basic Earnings Per Share
5.00%
-0.21
-0.20 -0.25 -0.26 -0.22
Diluted Earnings Per Share
5.00%
-0.21
-0.20 -0.25 -0.26 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.006
- 0.006 - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):